Catalyst
Slingshot members are tracking this event:
Additional cohort 1 data for Bellerophon's(BLPH) INOpulse delivery device in Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) due to be presented at ATS May 20, 2019
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
BLPH | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 21, 2019
Occurred Source:
http://investors.bellerophon.com/news-releases/news-release-details/bellerophon-presents-additional-positive-data-cohort-1-ongoing
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Inopulse Delivery Device, Pulmonary Arterial Hypertension, Interstitial Lung Disease